S100A9 and melanoma: Notably, our findings in a mouse model demonstrate that EMMPRIN interacts preferentially with S100A9, and this interaction promotes melanoma cell entry into the bloodstream and accumulation in skin tissue artificially enriched with S100A9 (Hibino et al.2013).